Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study: minimally-invasive sciatica treatment is no better than open surgery

This article was originally published in Clinica

Executive Summary

Tubular discectomy, a minimally-invasive approach to the surgical treatment of sciatica, is no better than the more common surgical technique, a study has concluded. The finding is bad news for Medtronic, whose METRx discectomy system is used to perform the procedure.

You may also be interested in...



Roche Steals A March In B-cell Lymphoma

New data on Columvi could allow the bispecific’s use as an earlier treatment, giving it a three-year head start on AbbVie and Genmab’s Epkinly.

PureTech Hopes For A Second Lightning Strike

Emerging Company Profile: Seaport Therapeutics believes its technology can alter old drugs to remove their flaws. Just how closely can it follow the example set by Karuna?

Semaglutide Might Treat Heart Failure Directly

Novo Nordisk’s product’s reputation as a wonder drug grows as new data suggest it might be disease-modifying in heart failure.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043760

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel